Showing all publications

Antibody-Dependent Effector Functions Against HIV Decline in Subjects Receiving Antiretroviral Therapy

Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D.
, 2015.

Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada

Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BDL; Montaner J; Lima VD; Olmstead AD.
, 2015.

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

Cummins NW; Neuhaus J; Chu H; Neaton J; Wyen C; Rockstroh JK; Skiest DJ; Boyd MA; Khoo S; Rotger M.
, 2015.

Pharmacogenetic testing can identify patients taking atazanavir at risk for hyperbilirubinaemia

Avihingsanon A; Tongkobpetch S; Kerr SJ; Punyawudho B; Suphapeetiporn K; Gorowara M; Ruxrungtham K; Shotelersuk V.
, 2015.

MAIT cells are depleted early but retain functional cytokine expression in HIV infection

Fernandez CS; Amarasena T; Kelleher AD; Rossjohn J; Mccluskey J; Godfrey DI; Kent SJ.
, 2015.

Recommendations for the management of hepatitis C virus infection among people who inject drugs

Grebely J; Robaeys G; Bruggmann P; Aghemo A; Backmund M; Bruneau J; Byrne J; Dalgard O; Feld JJ; Hellard M.
, 2015.